16 September 2026 editorial review · Trial
NNC0471-0119 H insulin: pump pharmacology study: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the trial evidence page →Primary-agent trial review — 16 September 2026
Assessment: New missed completed 43-person Phase 1 pump clamp; pharmacodynamic outcome and lack of posted results distinguished from glucose-control benefit.
Registry: NCT06809621; COMPLETED; updated 2026-09-10; enrollment 43 (ACTUAL); results not posted.
Endpoint comparison: AUC(GIR,0-1h,basal-corrected): Area under the basal-corrected glucose infusion rate (GIR)-time curve from 0 to 1 hour (0 to 1 hour after bolus infusion).
Sources for this record: A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin Pump (NCT06809621) (registry).
Limits: Source access and review depth vary. Registry fields establish the registered study, not clinical benefit, product approval or current local access. Cited-source reachability alone was not treated as verification of its claims.